| Business Summary | | Embryo
Development
Corporation
is
a
development-stage
corporation
that
develops,
acquires,
manufactures
and
markets
various
bio-medical
devices.
The
Company
has
licensed
a
patent
for
a
product
that
is
being
developed
to
be
sold
in
the
medical
field.
Embryo
has
not
derived
any
significant
revenues
since
its
inception.
In
addition,
the
Company
holds
patents
for
products
in
two
distinct
market
segments,
emergency
medical
equipment
and
peritoneal
dialysis
warming
devices.
The
patents
are
to
five
medical
devices;
two
of
these,
the
Hot-Sack
II
and
Hot-Sack
II+,
are
used
in
the
warming
of
peritoneal
dialysis
solution,
and
four
of
these,
Hot-Sack,
Res-Q-Air,
Therm-O-Drug
and
an
electronic
stethoscope,
are
devices
used
for
emergency
rescue
operations
and
by
other
emergency
medical
technicians.
The
Company
also
holds
a
13.1%
minority
investment
interest
in
Hydrogel
Design
Systems,
Inc.,
a
company
engaged
in
the
manufacturing,
marketing,
selling
and
distribution
of
hydrogel
materials. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | EMBR
is
a
development
stage
company
engaged
in
the
development,
acquisition,
manufacture
and
marketing
of
various
bio-medical
devices
in
two
market
segments:
emergency
medical
equipment
and
peritoneal
dialysis
warming
devices.
For
the
fiscal
year
ended
4/30/01,
revenues
fell
98%
to
$1
thousand.
Net
loss
decreased
66%
to
$390
thousand.
Revenues
reflect
ceased
sales
of
the
C.F.
Medical
devices.
Lower
loss
reflects
decreased
S/G/A
and
R&D
expenditures. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000 Pay | |
| Matthew Harriton, 36 Pres,
CEO, Chief Financial Officer | $60K | Dollar amounts are as of 30-Apr-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|